المؤلفون: Kasper Mønsted Pedersen, Hans Carl Hasselbalch, Stig E. Bojesen, Yunus Çolak, Børge G. Nordestgaard

المصدر: Pedersen, K M, Çolak, Y, Hasselbalch, H C, Bojesen, S E & Nordestgaard, B G 2020, ' Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm ', EClinicalMedicine, vol. 22, 100337 . https://doi.org/10.1016/j.eclinm.2020.100337Test
EClinicalMedicine, Vol 22, Iss, Pp-(2020)

مصطلحات موضوعية: lcsh:R5-920, business.industry, General Medicine, medicine.disease, chemistry.chemical_compound, Germline mutation, Tocilizumab, Soluble Interleukin 6 Receptor, chemistry, medicine, Cancer research, lcsh:Medicine (General), business, Myeloproliferative neoplasm

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cbd046939d92c1426f2922dd98bbf69Test
https://doi.org/10.1016/j.eclinm.2020.100337Test

المصدر: EClinicalMedicine.

مصطلحات موضوعية: Soluble Interleukin 6 Receptor, Germline mutation, business.industry, Cancer research, Medicine, In patient, General Medicine, business, medicine.disease, Myeloproliferative neoplasm

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d8ee67fd16c188a85c22b557e788119eTest